CRISPR and Genome Editing – News and Features

An investigational gene therapy for a rare neurodegenerative disease that begins in early childhood, known as giant axonal neuropathy, was well tolerated and showed signs of therapeutic benefit in a clinical trial.

Researchers at the University of Zurich and the University Hospital Zurich have discovered that a specific mutation in the cancer cells of an aggressive type of blood cancer can prevent novel immunotherapies such as CAR T-cell therapy from working.

Researchers have identified two enzymes that work against the chemotherapy drug gemcitabine, preventing it from treating pancreatic cancer.

A Washington State University-led research team pinpointed a set of genes in wild soil bacteria that allows them to do this in serpentine soils which have naturally high concentrations of toxic nickel.

Despite the unappealing origins of the fake meat, burgers derived from different fungi species have become supermarket staples in recent years thanks to rising consumer interest in environmental sustainability and meat-free lifestyles.

Scientists at the Massachusetts Institute of Technology have developed a rapid gene-editing screen to explore the effects of cancer mutations.

New research has unveiled new clues behind T-cell metabolism, that could enhance immunotherapies that rely on T cells to fight cancer.

Researchers have developed a microbial fermentation method to produce galantamine with the help of artificial intelligence (AI) and biosensors.

CRISPR-based test detects a genetic target that is specific to Burkholderia pseudomallei, the bacterium that causes melioidosis, with 93% sensitivity.

Just days after a single treatment of a new cell therapy, three glioblastoma patients experienced dramatic reductions in their tumors.